PISANTI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 480
EU - Europa 49
AS - Asia 18
Totale 547
Nazione #
US - Stati Uniti d'America 478
IT - Italia 24
IN - India 13
DE - Germania 6
SE - Svezia 6
GB - Regno Unito 4
UA - Ucraina 3
CA - Canada 2
CN - Cina 2
NL - Olanda 2
AL - Albania 1
FI - Finlandia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
PK - Pakistan 1
PL - Polonia 1
Totale 547
Città #
Chandler 139
Ashburn 63
Lawrence 22
Millbury 20
Boston 16
Des Moines 12
Wilmington 11
Washington 10
Naples 6
Pune 4
Fairfield 3
Los Angeles 3
New Delhi 3
Norwalk 3
Rome 3
Amsterdam 2
Council Bluffs 2
Kronberg 2
Napoli 2
Rosate 2
Seattle 2
Turin 2
Woodbridge 2
Ardabil 1
Augusta 1
Capaccio 1
Changsha 1
Dallas 1
Dublin 1
Gurgaon 1
Hanover 1
Herrischried 1
Jacksonville 1
Lappeenranta 1
Leawood 1
Luhansk 1
Mianwali 1
Milan 1
Mumbai 1
Nanjing 1
New Orleans 1
Ottawa 1
Richmond 1
San Mateo 1
Tel Aviv 1
Tirana 1
Urgnano 1
Warsaw 1
Totale 359
Nome #
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 38
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 37
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives 34
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 32
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 31
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth 29
Mangostanin, a Xanthone Derived from Garcinia mangostana Fruit, Exerts Protective and Reparative Effects on Oxidative Damage in Human Keratinocytes 26
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" 25
Headaches in the medieval Medical School of Salerno 25
Cannabinoids and cancer: pros and cons of an antitumour strategy 23
Pharmacological actions of statins: A critical appraisal in the management of cancer 23
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells 22
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 21
Lessons from the 1656 Neapolitan Plague: Something to learn for the current coronavirus Pandemic? 20
Integrating Medical Humanities into medical school training 19
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 19
The endocannabinoid signaling system in cancer 18
Tumor-associated macrophage status in cancer treatment 18
Ganoderma lucidum ethanol extracts enhance re-epithelialization and prevent keratinocytes from free-radical injury 17
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 17
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 17
Trotula de Ruggiero: The Magistra mulier sapiens and her medical dermatology treatises 17
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis 17
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 15
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 13
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon? 13
Totale 586
Categoria #
all - tutte 2.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 2 0 0 0
2019/20203 2 1 0 0 0 0 0 0 0 0 0 0
2020/202146 0 1 1 0 0 0 29 8 1 0 6 0
2021/2022136 1 0 1 0 1 7 5 4 9 8 40 60
2022/2023268 33 45 6 14 34 27 0 25 55 9 19 1
2023/2024131 7 25 10 24 20 37 1 5 2 0 0 0
Totale 586